Cargando…

Low Level Donor Chimerism of CD19 CAR-T Cells Returned to Complete Donor Chimerism in Patients with Relapse After Allo-Hematopoietic Stem Cell Transplant

PURPOSE: To investigate the donor chimerism changes and curative effects associated with the use of autologous anti-CD19 chimeric antigen receptor (CAR) T cells with B-cell acute lymphoblastic leukemia (B-ALL) presenting with a low donor chimerism level and relapse after allogeneic hematopoietic ste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qing, Mu, Juan, Yuan, Jijun, Yang, Zhenxing, Wang, Jia, Deng, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665456/ https://www.ncbi.nlm.nih.gov/pubmed/33204102 http://dx.doi.org/10.2147/OTT.S277146

Ejemplares similares

Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
por: Lindahl, Hannes, et al.
Publicado: (2022)

Unusual isolated extramedullary relapse of acute lymphoblastic leukemia in the breast despite complete donor hematopoietic chimerism after allogeneic hematopoietic stem cell transplantation
por: Sung, Pack Hyun, et al.
Publicado: (2018)

Donor derived hematopoietic stem cell niche transplantation facilitates mixed chimerism mediated donor specific tolerance
por: Zhang, Wensheng, et al.
Publicado: (2023)

Utility of saliva and hair follicles in donor selection for hematopoietic stem cell transplantation and chimerism monitoring
por: Kaur, Gurvinder, et al.
Publicado: (2012)

Systematic comparison of donor chimerism in peripheral blood and bone marrow after hematopoietic stem cell transplantation
por: Bach, C, et al.
Publicado: (2017)

Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation
por: Jiang, Ying, et al.
Publicado: (2015)

P1387: MONITORING OF DONOR CHIMERISM ON RED BLOOD CELLS ANTIGENS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Yovdiy, A., et al.
Publicado: (2022)

Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia
por: Aldoss, Ibrahim, et al.
Publicado: (2023)

Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts
por: Cwykiel, Joanna, et al.
Publicado: (2021)

Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease
por: Chu, Yaya, et al.
Publicado: (2022)

Case report: Rare persistent complete donor chimerism and GVHD following micro-transplantation from HLA haplotype homozygous donors
por: Liu, Lingling, et al.
Publicado: (2022)

Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT
por: Yang, Yingying, et al.
Publicado: (2019)

Generation of vascular chimerism within donor organs
por: Cohen, Shahar, et al.
Publicado: (2021)

Improved donor chimerism in relapse myelofibrosis post allogenic stem cell transplant with azacitidine and oral decitabine—First case report
por: Cheung, Verna, et al.
Publicado: (2022)

Skin Recurrence of Transformed Mycosis Fungoides Postumbilical Cord Blood Transplant despite Complete Donor Chimerism
por: Pawar, Rahul, et al.
Publicado: (2014)

Chimerism Testing by Next Generation Sequencing for Detection of Engraftment and Early Disease Relapse in Allogeneic Hematopoietic Cell Transplantation and an Overview of NGS Chimerism Studies
por: Liacini, Abdelhamid, et al.
Publicado: (2023)

Genome-edited allogeneic donor “universal” chimeric antigen receptor T cells
por: Qasim, Waseem
Publicado: (2023)

PB1843: DONOR-DERIVED CLL-1 CHIMERIC ANTIGEN RECEPTOR T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA BRIDGING TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE REPORT
por: Miao, Xiaojuan, et al.
Publicado: (2023)

Hematopoietic Chimerism and Transplantation Tolerance: A Role for Regulatory T Cells
por: Pasquet, Lise, et al.
Publicado: (2011)

Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation
por: Gille, Ilse, et al.
Publicado: (2022)

Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia
por: Rujkijyanont, P, et al.
Publicado: (2013)

Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy
por: Gandhi, Arpita P., et al.
Publicado: (2023)

Chimeric Antigen Receptor beyond CAR-T Cells
por: Qin, Vicky Mengfei, et al.
Publicado: (2021)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
por: Galli, Eugenio, et al.
Publicado: (2021)

Humanized Chimeric Antigen Receptor (CAR) T cells
por: Kozani, Pouya Safarzadeh, et al.
Publicado: (2021)

CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation
por: Martínez-Romera, Isabel, et al.
Publicado: (2022)

Genome editing of donor-derived T cells to generate allogeneic chimeric antigen receptor-modified T cells: optimizing αβ T-cell-depleted haploidentical hematopoietic stem cell transplantation
por: Wiebking, Volker, et al.
Publicado: (2020)

Generation of donor organs in chimeric animals via blastocyst complementation
por: Babochkina, T.I., et al.
Publicado: (2020)

Low donor chimerism may be sufficient to prevent demyelination in adrenoleukodystrophy
por: Ikeda, Takahiro, et al.
Publicado: (2021)

PB2441: CD34+ CELL DOSE EFFECTS ON CLINICAL OUTCOMES OF ALLO-HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT)
por: Zhou, Shengnan, et al.
Publicado: (2023)

Persistent Mixed Donor Chimerism following Double Umbilical Cord Transplantation in a Patient with T-Cell Prolymphocytic Leukemia
por: Mistry, Ronak H., et al.
Publicado: (2019)

The Macrophage-depleting Agent Clodronate Promotes Durable Hematopoietic Chimerism and Donor-specific Skin Allograft Tolerance in Mice
por: Li, Zhanzhuo, et al.
Publicado: (2016)

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2019)

Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation
por: Gagelmann, Nico, et al.
Publicado: (2023)

Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies
por: Yang, Chieh, et al.
Publicado: (2023)

Optimization of Donor Lymphocyte Infusion for AML Relapse After Allo-HCT in the Era of New Drugs and Cell Engineering
por: Ye, Yishan, et al.
Publicado: (2022)

Engraftment of donor mesenchymal stem cells in chimeric BXSB includes vascular endothelial cells and hepatocytes
por: Jones, Olcay Y, et al.
Publicado: (2011)

The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
por: Ljungman, Per, et al.
Publicado: (2020)

Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation
por: Srour, Samer A., et al.
Publicado: (2019)

Understanding and using AlloSure donor derived cell-free DNA
por: Seeto, R. K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jrpuo3rhhj7u77b6u2tljiuj9s